The Pan European Emesis Registry (PEER): a critical appraisal of the Italian experiencePASTORELLI, Davide; LOCATELLI, Maria Adelia; GIORDANO, Anna et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 5, pp 309-317, issn 1120-009X, 9 p.Article

Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature reviewMARX, Wolfgang M; TELENI, Laisa; MCCARTHY, Alexandra L et al.Nutrition reviews. 2013, Vol 71, Num 4, pp 245-254, issn 0029-6643, 10 p.Article

Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomitingJANICKI, Piotr K; SUGINO, Shigekazu.Experimental brain research. 2014, Vol 232, Num 8, pp 2613-2625, issn 0014-4819, 13 p.Conference Paper

Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjectsBLUM, Robert A; MAJUMDAR, Anup; GOTTESDIENER, Kevin M et al.Clinical therapeutics. 2003, Vol 25, Num 5, pp 1407-1419, issn 0149-2918, 13 p.Article

Aprepitant: drug-drug interactions in perspectiveAAPRO, M. S; WALKO, C. M.Annals of oncology. 2010, Vol 21, Num 12, pp 2316-2323, issn 0923-7534, 8 p.Article

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapyGRALLA, R. J; BOSNJAK, S. M; HONTSA, A et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1333-1339, issn 0923-7534, 7 p.Article

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal studyHESKETH, P. J; ROSSI, G; RIZZI, G et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1340-1346, issn 0923-7534, 7 p.Article

Update and new trends in antiemetic therapy: the continuing need for novel therapiesFEYER, P; JORDAN, K.Annals of oncology. 2011, Vol 22, Num 1, pp 30-38, issn 0923-7534, 9 p.Article

Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapyJORDAN, Karin; KINITZ, Iris; VOIGT, Wieland et al.European journal of cancer (1990). 2009, Vol 45, Num 7, pp 1184-1187, issn 0959-8049, 4 p.Article

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyAAPRO, M; RUGO, H; KARTHAUS, M et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1328-1333, issn 0923-7534, 6 p.Article

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapyAAPRO, M; FABI, A; NOLE, F et al.Annals of oncology. 2010, Vol 21, Num 5, pp 1083-1088, issn 0923-7534, 6 p.Article

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapyMAEMONDO, M; MASUDA, N; SEKINE, I et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1860-1866, issn 0923-7534, 7 p.Article

Clonazepam for Chemotherapy-induced Nausea and Vomiting (CINV)KOGA, Minako; NAKADOZONO, Momoe; NUKARIYA, Kazutaka et al.Anticancer research. 2008, Vol 28, Num 4C, pp 2433-2436, issn 0250-7005, 4 p.Article

Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescentsSMITH, Angela R; REPKA, Tanya L; WEIGEL, Brenda J et al.Pediatric blood & cancer. 2005, Vol 45, Num 6, pp 857-860, issn 1545-5009, 4 p.Article

Comparative activity of antiemetic drugsJORDAN, Karin; SCHMOLL, Hans J; AAPRO, Matti S et al.Critical reviews in oncology/hematology. 2007, Vol 61, Num 2, pp 162-175, issn 1040-8428, 14 p.Article

Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCTMUSSO, M; SCALONE, R; CRESCIMANNO, A et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 1, pp 123-127, issn 0268-3369, 5 p.Article

Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapyFASCHING, P. A; KOLLMANNSBERGER, B; BECKMANN, M. W et al.Journal of cancer research and clinical oncology. 2008, Vol 134, Num 10, pp 1079-1086, issn 0171-5216, 8 p.Article